QQQ   437.60 (+0.24%)
AAPL   182.63 (+0.81%)
MSFT   407.48 (-0.01%)
META   487.05 (+1.10%)
GOOGL   138.88 (+0.95%)
AMZN   173.54 (-0.68%)
TSLA   199.73 (+0.17%)
NVDA   787.01 (-0.49%)
NIO   5.78 (+2.30%)
AMD   178.00 (+1.13%)
BABA   77.68 (+1.53%)
T   16.83 (+1.39%)
F   12.00 (+0.42%)
MU   91.85 (+2.67%)
CGC   3.53 (+1.73%)
GE   153.99 (-0.50%)
DIS   109.42 (+1.62%)
AMC   4.81 (+8.09%)
PFE   26.89 (-1.07%)
PYPL   60.16 (+1.40%)
XOM   104.03 (-0.21%)
QQQ   437.60 (+0.24%)
AAPL   182.63 (+0.81%)
MSFT   407.48 (-0.01%)
META   487.05 (+1.10%)
GOOGL   138.88 (+0.95%)
AMZN   173.54 (-0.68%)
TSLA   199.73 (+0.17%)
NVDA   787.01 (-0.49%)
NIO   5.78 (+2.30%)
AMD   178.00 (+1.13%)
BABA   77.68 (+1.53%)
T   16.83 (+1.39%)
F   12.00 (+0.42%)
MU   91.85 (+2.67%)
CGC   3.53 (+1.73%)
GE   153.99 (-0.50%)
DIS   109.42 (+1.62%)
AMC   4.81 (+8.09%)
PFE   26.89 (-1.07%)
PYPL   60.16 (+1.40%)
XOM   104.03 (-0.21%)
QQQ   437.60 (+0.24%)
AAPL   182.63 (+0.81%)
MSFT   407.48 (-0.01%)
META   487.05 (+1.10%)
GOOGL   138.88 (+0.95%)
AMZN   173.54 (-0.68%)
TSLA   199.73 (+0.17%)
NVDA   787.01 (-0.49%)
NIO   5.78 (+2.30%)
AMD   178.00 (+1.13%)
BABA   77.68 (+1.53%)
T   16.83 (+1.39%)
F   12.00 (+0.42%)
MU   91.85 (+2.67%)
CGC   3.53 (+1.73%)
GE   153.99 (-0.50%)
DIS   109.42 (+1.62%)
AMC   4.81 (+8.09%)
PFE   26.89 (-1.07%)
PYPL   60.16 (+1.40%)
XOM   104.03 (-0.21%)
QQQ   437.60 (+0.24%)
AAPL   182.63 (+0.81%)
MSFT   407.48 (-0.01%)
META   487.05 (+1.10%)
GOOGL   138.88 (+0.95%)
AMZN   173.54 (-0.68%)
TSLA   199.73 (+0.17%)
NVDA   787.01 (-0.49%)
NIO   5.78 (+2.30%)
AMD   178.00 (+1.13%)
BABA   77.68 (+1.53%)
T   16.83 (+1.39%)
F   12.00 (+0.42%)
MU   91.85 (+2.67%)
CGC   3.53 (+1.73%)
GE   153.99 (-0.50%)
DIS   109.42 (+1.62%)
AMC   4.81 (+8.09%)
PFE   26.89 (-1.07%)
PYPL   60.16 (+1.40%)
XOM   104.03 (-0.21%)
CVE:HEM

Hemostemix (HEM) Stock Price, News & Analysis

C$0.07
+0.01 (+7.69%)
(As of 02:14 PM ET)
Today's Range
C$0.07
C$0.07
50-Day Range
C$0.07
C$0.11
52-Week Range
C$0.07
C$0.21
Volume
54,000 shs
Average Volume
38,920 shs
Market Capitalization
C$6.29 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

HEM stock logo

About Hemostemix Stock (CVE:HEM)

Hemostemix Inc., a clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions. The company develops cell therapy products from the patient's own blood, which is a non-invasive source of therapeutic cells. Its lead product is ACP-01, an autologous cell therapy, which is in Phase II clinical trial for the treatment of vascular diseases, such as cardiovascular disease, peripheral arterial disease, angina pectoris, and ischemia in Canada and the United States. The company is also developing various types of cell products, such as synergetic cell populations, neural cell precursors, and cardiomyocyte cell precursors. Hemostemix Inc. is headquartered in Calgary, Canada.

HEM Stock Price History

HEM Stock News Headlines

Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
Hemostemix Inc HMTXF
Closing Bell: Hemostemix Inc down on Thursday (HEM)
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Closing Bell: Hemostemix Inc up on Friday (HEM)
Closing Bell: Hemostemix Inc up on Tuesday (HEM)
Closing Bell: Hemostemix Inc down on Monday (HEM)
Closing Bell: Hemostemix Inc flat on Wednesday (HEM)
Hemostemix's Private Placement Use of Proceeds
Closing Bell: Hemostemix Inc down on Friday (HEM)
Closing Bell: Hemostemix Inc flat on Tuesday (HEM)
Closing Bell: Hemostemix Inc flat on Friday (HEM)
Closing Bell: Hemostemix Inc flat on Thursday (HEM)
Closing Bell: Hemostemix Inc up on Wednesday (HEM)
Closing Bell: Hemostemix Inc down on Tuesday (HEM)
Closing Bell: Hemostemix Inc up on Monday (HEM)
Closing Bell: Hemostemix Inc down on Wednesday (HEM)
See More Headlines
Receive HEM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hemostemix and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
2/27/2024
Next Earnings (Estimated)
3/25/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
C$-3,170,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Cash Flow
C$0.01 per share
Book Value
C($0.08) per share

Miscellaneous

Free Float
N/A
Market Cap
C$5.84 million
Optionable
Not Optionable
Beta
0.52
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report














HEM Stock Analysis - Frequently Asked Questions

How have HEM shares performed in 2024?

Hemostemix's stock was trading at C$0.07 at the start of the year. Since then, HEM shares have increased by 0.0% and is now trading at C$0.07.
View the best growth stocks for 2024 here
.

When is Hemostemix's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, March 25th 2024.
View our HEM earnings forecast
.

What other stocks do shareholders of Hemostemix own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Hemostemix investors own include Iplayco (IPC), Capricor Therapeutics (CAPR), Gene Biotherapeutics (CRXM), Camber Energy (CEI), Auxly Cannabis Group (CBWTF), Cannabis Science (CBIS), Beazer Homes USA (BZH), Big Tree Group (BIGG), Asterias Biotherapeutics (AST) and

How do I buy shares of Hemostemix?

Shares of HEM stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (CVE:HEM) was last updated on 2/27/2024 by MarketBeat.com Staff